• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Radioiodine therapy in patients with stage I differentiated thyroid cancer.

作者信息

Jonklaas Jacqueline, Cooper David S, Ain Kenneth B, Bigos Thomas, Brierley James D, Haugen Bryan R, Ladenson Paul W, Magner James, Ross Douglas S, Skarulis Monica C, Steward David L, Maxon Harry R, Sherman Steven I

出版信息

Thyroid. 2010 Dec;20(12):1423-4. doi: 10.1089/thy.2010.0308. Epub 2010 Nov 7.

DOI:10.1089/thy.2010.0308
PMID:21054207
Abstract
摘要

相似文献

1
Radioiodine therapy in patients with stage I differentiated thyroid cancer.I期分化型甲状腺癌患者的放射性碘治疗
Thyroid. 2010 Dec;20(12):1423-4. doi: 10.1089/thy.2010.0308. Epub 2010 Nov 7.
2
[Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].[放射性碘治疗弥漫性乳头状和滤泡状甲状腺癌]
Duodecim. 2014;130(6):573-9.
3
[CME: Radioactive iodine therapy in thyroid cancer].[继续医学教育：甲状腺癌的放射性碘治疗]
Praxis (Bern 1994). 2015 Nov 11;104(23):1235-43; quiz 1244-5. doi: 10.1024/1661-8157/a002189.
4
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.手术、放射性碘及外照射放疗对分化型甲状腺癌患者临床结局的影响。
Cancer. 1998 Jan 15;82(2):375-88.
5
Radioiodine therapy for papillary and follicular thyroid carcinoma.放射性碘治疗乳头状和滤泡状甲状腺癌。
Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S479-85. doi: 10.1007/s00259-002-0810-9. Epub 2002 May 9.
6
The role of total thyroidectomy in the management of differentiated thyroid cancer.全甲状腺切除术在分化型甲状腺癌治疗中的作用。
Curr Opin Gen Surg. 1994:53-9.
7
Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).分化型甲状腺癌。辅助性外照射放疗对甲状腺周围肿瘤浸润患者（pT4期）的影响。
Cancer. 1996 Jan 1;77(1):172-80. doi: 10.1002/(SICI)1097-0142(19960101)77:1<172::AID-CNCR28>3.0.CO;2-1.
8
[The basis for radioiodine therapy in differentiated thyroid cancer].[分化型甲状腺癌放射性碘治疗的基础]
Ther Umsch. 1999 Jul;56(7):403-7. doi: 10.1024/0040-5930.56.7.403.
9
Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma.放射性碘在乳头状和滤泡状甲状腺癌患者术后管理中的选择性应用。
J Surg Oncol. 2006 Dec 15;94(8):692-700. doi: 10.1002/jso.20696.
10
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal.用30毫居里的碘-131消融甲状腺残留组织：重组人促甲状腺素或甲状腺激素撤药准备的甲状腺癌患者的比较。
J Clin Endocrinol Metab. 2002 Sep;87(9):4063-8. doi: 10.1210/jc.2001-011918.

引用本文的文献

1
Evolving Paradigm in Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Historical Perspectives, Current Practices and Future Directions.分化型甲状腺癌放射性碘治疗的发展范式：历史回顾、当前实践与未来方向
Diagnostics (Basel). 2025 Jun 5;15(11):1438. doi: 10.3390/diagnostics15111438.
2
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-II.分化型甲状腺癌的放射性碘治疗：从核医学角度看韩国甲状腺协会2024年指南总结，第二部分
Nucl Med Mol Imaging. 2025 Feb;59(1):8-26. doi: 10.1007/s13139-024-00886-x. Epub 2024 Nov 1.
3
Efficacy of postoperative radioactive iodine therapy for patients with low and intermediate risk papillary thyroid carcinoma.
低中危乳头状甲状腺癌患者术后放射性碘治疗的疗效
Endocrine. 2025 Feb;87(2):685-696. doi: 10.1007/s12020-024-04046-1. Epub 2024 Sep 23.
4
The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review.低分化甲状腺癌（PDTC）个体化靶向治疗的漫长征程：一例病例报告及系统综述
J Pers Med. 2024 Jun 18;14(6):654. doi: 10.3390/jpm14060654.
5
Is radioiodine ablation with 1.1 GBq (30 mCi) I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study.1.1GBq（30mCi）放射性碘消融术对低危甲状腺癌患者是否必要？一项长期随访前瞻性研究的结果。
Endocrine. 2023 Jun;80(3):606-611. doi: 10.1007/s12020-023-03306-w. Epub 2023 Mar 29.
6
Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).低危型甲状腺乳头状癌的治疗策略：巴西内分泌学会甲状腺分会的立场声明。
Arch Endocrinol Metab. 2022;66(4):522-532. doi: 10.20945/2359-3997000000512.
7
Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer.甲状腺癌患者接受131碘治疗后实施常规SPECT-CT成像的临床经验。
Endocr Connect. 2022 May 25;11(5):e210371. doi: 10.1530/EC-21-0371.
8
Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.放射性碘治疗儿童和青年分化型甲状腺癌与第二原发恶性肿瘤风险的关系。
J Clin Oncol. 2022 May 1;40(13):1439-1449. doi: 10.1200/JCO.21.01841. Epub 2022 Jan 19.
9
The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer.桥本甲状腺炎在预测低危和中危分化型甲状腺癌放射性碘消融疗效和预后中的作用。
Ann Nucl Med. 2021 Oct;35(10):1089-1099. doi: 10.1007/s12149-021-01644-1. Epub 2021 Jun 21.
10
Patient Perspectives on the Extent of Surgery and Radioactive Iodine Treatment for Low-Risk Differentiated Thyroid Cancer.患者对低危分化型甲状腺癌手术和放射性碘治疗范围的看法。
Endocr Pract. 2021 May;27(5):383-389. doi: 10.1016/j.eprac.2021.01.005. Epub 2021 Jan 16.